(Q42537091)

1 November 2017

title

Potent beta-lactam inhibitors of human cytomegalovirus protease (English)

1 reference

1 November 2017

0 references

C Yoakim

1

1 reference

1 November 2017

W W Ogilvie

2

1 reference

1 November 2017

D R Cameron

3

1 reference

1 November 2017

C Chabot

4

1 reference

1 November 2017

C Grand-Maître

5

1 reference

1 November 2017

I Guse

6

1 reference

1 November 2017

B Haché

7

1 reference

1 November 2017

S Kawai

8

1 reference

1 November 2017

J Naud

9

1 reference

1 November 2017

J A O'Meara

10

1 reference

1 November 2017

R Plante

11

1 reference

1 November 2017

R Déziel

12

1 reference

1 November 2017

publication date

1 September 1998

1 reference

Antiviral Chemistry & Chemotherapy

1 November 2017

published in

1 reference

1 November 2017

volume

9

1 reference

1 November 2017

issue

5

1 reference

1 November 2017

page(s)

379-387

1 reference

Design and synthesis of monocyclic beta-lactams as mechanism-based inhibitors of human cytomegalovirus protease

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900502

Structure of the human cytomegalovirus protease catalytic domain reveals a novel serine protease fold and catalytic triad.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900502

Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900502

Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900502

Herpesvirus proteases: targets for novel antiviral drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900502

Peptidomimetic inhibitors of the human cytomegalovirus protease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900502

Processing of the herpes simplex virus assembly protein ICP35 near its carboxy terminal end requires the product of the whole of the UL26 reading frame

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900502

Unique fold and active site in cytomegalovirus protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900502

Families of serine peptidases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900502

Three-dimensional structure of human cytomegalovirus protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900502

In vitro proteolytic activity and active-site identification of the human cytomegalovirus protease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900502

A new serine-protease fold revealed by the crystal structure of human cytomegalovirus protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900502

Foscarnet. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900502

A facile synthesis of chiral N-protected β-amino alcohols

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F095632029800900502

10.1177/095632029800900502

21 January 2018

Identifiers

DOI

1 reference

1 November 2017

1 reference